Athyrium Capital Management, LP Insider Profile
4 Followers
Athyrium Capital Management, LP, Ten Percent Owner at Biora Therapeutics, holds 36.40M shares in Biora Therapeutics (Ticker: BIORQ). Most recently, Athyrium Capital Management, LP Bought 8,097,166 shares of Biora Therapeutics on Jun 14, 2021 for an estimated value of $20.00M.
Athyrium Capital Management, LP's Trading History
| BIORQBiora Therapeutics | Jun 14, 2021 | Ten Percent Owner | Informative Buy | 20.00M | ― | |
You May Also Like
Athyrium Capital Management, LP insider profile FAQ
What is the percentage of profitable transactions made by Athyrium Capital Management, LP?
The percentage of profitable transactions made by Athyrium Capital Management, LP is 0%.
What is the average return per transaction made by Athyrium Capital Management, LP?
The average return per transaction made by Athyrium Capital Management, LP is -72.20%.
What stocks does Athyrium Capital Management, LP hold?
Athyrium Capital Management, LP holds: BIORQ stocks.
What was Athyrium Capital Management, LP’s latest transaction?
Athyrium Capital Management, LP’s latest transaction was an Informative Buy of $20.00M.
What was Athyrium Capital Management, LP's most profitable transaction?
Athyrium Capital Management, LP’s most profitable transaction was an Informative Buy of BIORQ stock on June 25, 2020. The return on the trade was -62.30%.
What is Athyrium Capital Management, LP's role in Biora Therapeutics?
Athyrium Capital Management, LP's role in Biora Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
